Key Dates
None
National Cancer Institute (NCI)
The National Cancer Institute (NCI) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to invite U01 cooperative agreement applications that apply systems-level approaches to tackle questions in metastasis that will integrate with and complement ongoing research in the Metastasis Research Network (MetNet). Successful U01 Research Projects will join the MetNet.
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in late summer 2022 with an expected application due date in fall 2022. This FOA will utilize the U01 activity code. Details of the planned FOA are provided below.
This Notice encourages investigators with expertise and insights into metastasis and metastatic processes to begin to consider applying for this new FOA.
The MetNet is a collection of Research Centers that support using systems-level approaches to understand the non-linear, dynamic, and emergent processes in metastasis. Considering chronological progression and biological scales, the MetNet seeks to collectively derive a more comprehensive and cohesive picture of metastasis as a whole body, systems-level problem.
This upcoming FOA will invite U01 cooperative agreement applications for MetNet Research Projects. These Research Projects should be defined, discrete entities that use systems-level approaches to address gaps and opportunities in metastasis research that will integrate with and complement ongoing research within the MetNet Centers.
Collaborative investigations combining expertise from metastasis, cancer biology, engineering, systems biology, physiology, and physical oncology fields are encouraged and these investigators should also begin considering applying to this FOA.
Among the areas of research encouraged by this initiative are themes of early dissemination and crosstalk as they apply to metastasis from the lung, prostate, pancreas, liver, kidney, bladder, or ovary; metastasis to sites such as the bone or lung or rare sites; and associated metastatic processes such as the establishment of, maintenance of, or emergence from dormancy. Investigations that explore mechanisms of metastasis in cancers with rising mortality rates and those with high incidence in diverse populations are highly encouraged.
TBD
TBD
$500,000 per year direct costs
93.396
Applications are not being solicited at this time.
Please direct all inquiries to:
Joanna M. Watson, Ph.D.
National Cancer Institute (NCI)
240-276-6206
Email: watsonjo@mail.nih.gov